10 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... DVT = deep vein ... #DOAC #VTE #Malignancy ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Portal Vein Thrombosis - Anticoagulation and Management Algorithm
When to start anticoagulation for portal vein thrombosis

#PVT #PortalVein
- Anticoagulation ... and Management ... #PVT #PortalVein ... #Management #Algorithm ... #treatment
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
for First Time DVT ... Unprovoked • Active Malignancy ... #DVT #Treatment ... #Algorithm #management ... hematology #VTE #thrombosis
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... catheter-related thrombosis ... without concomitant DVT ... #DOAC #VTE #Malignancy ... #Management #Hematology
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Thromboembolism Treatment ... Active malignancy ... @Clotmaster #Management ... #VTE #DVT #Algorithm ... #Hematology #Anticoagulation
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Upper Extremity DVT ... Provoked first DVT ... Bloodman #VTE #anticoagulation ... #duration #management ... #length #treatment
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management ... Algorithm #Anticoagulation ... #Breakthrough #Thrombosis ... Extension #VTE #DVT ... #Diagnosis #Differential
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
and Management ... 5-10d, venous (DVT ... Management: • ... , Bivalirudin, DOAC ... #Management #Treatment
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
or small-vessel thrombosis ... to be present Treatment ... Guidelines): • Anticoagulation ... target to 3-4 • DOACs ... #management #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... Splenomegaly Diagnosis ... A conclusive diagnosis ... Hydroxyurea + anticoagulation ... #management #hematology